Verition Fund Management LLC Tg Therapeutics, Inc. Transaction History
Verition Fund Management LLC
- $13 Billion
- Q1 2024
A detailed history of Verition Fund Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 16,657 shares of TGTX stock, worth $341,468. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,657
Previous 14,104
18.1%
Holding current value
$341,468
Previous $240,000
5.42%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TGTX
# of Institutions
269Shares Held
87.7MCall Options Held
2.72MPut Options Held
1.74M-
Vanguard Group Inc Valley Forge, PA13.5MShares$278 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.8MShares$222 Million0.0% of portfolio
-
State Street Corp Boston, MA7.8MShares$160 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.48MShares$71.4 Million0.02% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.33MShares$68.2 Million0.06% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $2.98B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...